Norverapamil
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 100mg in glass bottle |
| 产品描述: | 基本信息 产品编号: N11022 产品名称: Norverapamil CAS: 67018-85-3 储存条件 粉末 -20℃ 四年 分子式: C26H36N2O4 溶于液体 -80℃ 一年 分子量: 440.58 化学名: Benzeneacetonitrile,a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)- Solubility (25°C): 体外: DMSO Ethanol Water 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 生物活性 产品描述 Verapamil的N-去甲基代谢物,是一种钙通道(L-typecalciumchannel)阻滞剂和P-糖蛋白(P-gp)功能抑制剂。 靶点 Calcium channel blocker P-glycoprotein (P-gp) inhibitor 体外研究 Norverapamil ((±)-Norverapamil) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M.tuberculosis in the absence of other drugs.norverapamil,also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil.Verapamil and its major metabolite Norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic. 体内研究 Norverapamil (9mg/kg;p.o.),a major metabolite of verapamil,has terminal half-life,AUC and Cmax values of 9.4 hours,260ng▪h/ml,and 41.6ng/mL,respectively. Animal Model: Male Sprague-Dawley rats Dosage: 9mg/kg (Pharmacokinetic Study) Administration: Oral administration Result: t1/2=9.4 hours;AUC=260ng▪h/mL;Cmax=41.6ng/mL. |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

